Press release
Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Lewy Body Dementia
What Is the Projected Growth of the Lewy Body Dementia Market?
In recent times, the market size for Lewy body dementia has witnessed substantial growth. It is projected to increase from $1.12 billion in 2024 to $1.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The historic growth can be linked to the rise in the aging population, heightened awareness surrounding neurodegenerative diseases, increased healthcare spending, refined diagnostic criteria, and regulatory green lights for dementia medications.
Anticipated to experience robust expansion in the upcoming years, the market size of lewy body dementia is projected to reach $1.60 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. The market growth in this period can be credited to factors such as increased dementia prevalence, escalated investment in research and development, a push for early diagnosis, broader telemedicine application, and a focus on individualised medicine. The forecast period is set to see significant trends, such as the development of specialized treatments, the growth of clinical trials, advancements in diagnosis methods, technological progress, and a concentration on innovative therapeutics.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21213
What Are the Different Lewy Body Dementia Market Segments?
The lewy body dementia market covered in this report is segmented -
1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications
3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users
Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI), Genetic Biomarkers, Blood-Based Biomarkers
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21213&type=smp
What Are the Primary Drivers Shaping the Lewy Body Dementia Market?
The increase in brain-related disorders is predicted to fuel the expansion of the lewy body dementia market. These disorders include various conditions that disrupt the structure and functionality of the brain, leading to cognitive deterioration, memory impairment, and behavioural changes. The aging process, genetic factors, and environmental influencers are contributing to the growing incidence of these disorders. This rise, in turn, heightens the need for improved treatments and early detection of lewy body dementia, spurring research, funding, and innovation and paving the way for rapid progress in diagnosis and therapy for LBD. For example, the World Federation of Neurology reported in October 2023 that over 40% of the global population is suffering from neurological conditions, a number that's projected to nearly double by 2050. Consequently, the escalating incidence of brain-related disorders is set to steer the expansion trajectory of the lewy body dementia market.
Which Companies Are Leading in the Lewy Body Dementia Market?
Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer's Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
What Lewy Body Dementia Market Trends Are Gaining Traction Across Different Segments?
Key businesses in the lewy body dementia market are emphasizing on research funding to innovate more effective treatments for neurodegenerative conditions. This commitment to research investment typically necessitates substantial financial input, energy, and the investment of significant time into scientific and technological research. Such commitment is dedicated to acquiring new knowledge, formulating advanced solutions, or improving existing treatments. It aids disease investigation and the creation of new drugs, with the primary aim of enhancing patient outcomes. A prime example of this was in March 2023, where the US government affiliated National Institute on Aging granted $21 million in support of drug development research specifically for Lewy Body Dementia (LBD). Following promising preliminary results, researchers at the University of Miami Miller School of Medicine are commencing a Phase 2b study of neflamapimod.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-global-market-report
What Are the Top Revenue-Generating Geographies in the Lewy Body Dementia Market?
North America was the largest region in the lewy body dementia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Lewy Body Dementia Market?
2. What is the CAGR expected in the Lewy Body Dementia Market?
3. What Are the Key Innovations Transforming the Lewy Body Dementia Industry?
4. Which Region Is Leading the Lewy Body Dementia Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lewy Body Dementia Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4069503 • Views: …
More Releases from The Business Research Company
2025-2034 Superconducting Quantum Chip Market Outlook: Key Drivers, Emerging Cha …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Superconducting Quantum Chip Market Through 2025?
The market size of superconducting quantum chips has shown a swift expansion in the past few years. It's forecasted to surge from a value of $0.74 billion in 2024, reaching $0.87 billion in 2025, with a…
What Is Driving Global Responsible AI Governance Consulting Market Growth in 202 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Responsible AI Governance Consulting Market Size By 2025?
The market size for responsible AI governance consulting has seen substantial growth recently. Projections show it will expand from $0.29 billion in 2024 to $0.43 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 49.0%.…
Expansion Of Industrial Fleets Fueling The Growth Of The Market Due To Rising E- …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Material Handling Equipment Telematics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the telematics market for material handling equipment has experienced swift growth. The market is projected to increase from $5.42 billion in 2024 to $6.14 billion in 2025,…
Higher Educational Professional Audio-Visual (Pro AV) Market Poised to Hit $5.68 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Higher Educational Professional Audio-Visual (Pro AV) Industry Market Size Be by 2025?
The market size for professional audio-visual (pro av) in the higher education sector has seen robust growth in the past few years. The market is projected to increase from a value of $3.54 billion…
More Releases for Lewy
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused by the abnormal accumulation of alpha-synuclein protein (Lewy bodies) in the brain, leading to cognitive decline, visual hallucinations, fluctuating alertness, REM sleep behavior disorder, and Parkinsonism symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71909
With aging populations and rising awareness, the LBD market is…
Lewy Body Disease Pipeline: 10+ Innovators Advancing Disease-Modifying and Sympt …
Lewy Body Disease (LBD), including dementia with Lewy bodies and Parkinson's disease dementia, is a complex neurodegenerative condition attracting the attention of over 10 key companies such as Cognition Therapeutics, Eli Lilly and Company, Athira Pharma, and NLS Pharmaceutics. The LBD pipeline features therapies targeting alpha-synuclein, neuroprotective agents, and symptomatic treatments that address cognition, motor symptoms, and neuropsychiatric complications. With no approved disease-modifying treatment, this pipeline represents a vital frontier…
Lewy Body Dementia Treatment Market Challenges: Growth, Share, Value, Trends and …
Lewy Body Dementia Treatment Market Size And Forecast by 2031
The LBD Therapy Market is expanding rapidly, driven by increasing consumer demand, technological advancements, and industry-wide innovation. According to top market research firms, businesses in the Neurodegenerative Disorder Treatment Market are prioritizing digital transformation, product development, and data-driven decision-making to stay competitive. With rising investments in automation and efficiency, the Dementia Care Market is evolving to meet changing customer preferences.…
Lewy Body Dementia Treatment Market Focuses on Advancements in Diagnosis and The …
Global Lewy Body Dementia Treatment Market, By Drug Type (Cholinesterase Inhibitors, Antipsychotic Drugs, Antidepressants, Benzodiazepine, and Modafinil), Application Type (Parkinson's Disease and Alzheimer's Disease), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies and Others) - Industry Trends and Forecast to 2031.
Data Bridge Market Research analyses that the Global Lewy Body Dementia Treatment Market which was USD 5.66 Billion in 2023…
Lewy Body Dementia Treatment Market Analysis, Trends & Forecast 2024-2033 | Grow …
The lewy body dementia treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2023 to $4.41 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to supportive care and family education, regulatory approvals and guideline, multidisciplinary care approaches, psychosocial and behavioral interventions, multidisciplinary care approaches..
The lewy body dementia treatment…
Lewy Body Dementia Treatment Market to see Rapid Growth by 2029
The Lewy Body Dementia Treatment Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Lewy Body Dementia (LBD) affects people mostly aged 50 years and above. It accounts for about 1-2% of all the cases of dementia. Lewy body is also projected to be found in other neurological disorders such as Parkinson's disease and Alzheimer's disease. Furthermore, underdiagnosis and late…
